Stock analysts at William Blair assumed coverage on shares of TransMedics Group (NASDAQ:TMDX – Get Free Report) in a research report issued to clients and investors on Wednesday, FlyOnTheWall reports. The brokerage set an “outperform” rating on the stock. Separately, Oppenheimer upped their price target on shares of TransMedics Group from $85.00 to $90.00 in […]